Connect your AI

SION SION Investment Purchases

Investment Purchases at other companies

Vertex PharmaceuticalsVRTX

$2.51B+52.2%

BioCryst PharmaceuticalsBCRX

$0-100%

Neurocrine BiosciencesNBIX

$819.5M+200%

Other financials

Income statement

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

Market cap$1.86B—

Returns & leverage

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SION's investment purchases?: SION (SION) reported investment purchases of $25.33M in Q1 2026.
How has SION's investment purchases changed year-over-year?: SION's investment purchases decreased by 85.2% year-over-year, from $171.6M to $25.33M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.